https://doi.org/10.4081/monaldi.2022.1798
Two years progression-free survival under vinorelbine metronomic therapy of a patient with metastatic epithelioid hemangioendothelioma
Submitted: February 8, 2021
Accepted: March 30, 2022
Published: April 1, 2022
Accepted: March 30, 2022
Abstract Views: 999
PDF: 337
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Epithelioid hemangioendothelioma (EHE) is a very rare vascular tumor, originating from endothelial cells. The etiology of EHE is unknown, yet at the molecular level, different angiogenic stimulators may act as promoters of endothelial cell proliferation. The tumor affects more commonly the lung, the liver and the bones but it can affect any other organ. Due to its heterogeneous presentation and its rarity it is often misdiagnosed. No treatment is proved to be efficient in metastatic EHE and the median survival of patients with metastatic pleural disease is generally poor, less than one year. we report a case of a 57-year-old female with multiple metastatic EHE including pleural, diagnosed by medical thoracoscopy, with a progression-free survival of 24 months with oral vinorelbine as maintenance therapy after combination of cisplatin-vinorelbine. We believe that this therapy might be of value to test in this patient population as it has never been tested before.
Dail DH, Liebow AA, Gmelich JT, et al. Intravascular, bronchiolar, and alveolar tumor of the lung (IVBAT). An analysis of twenty cases of a peculiar sclerosing endothelial tumor. Cancer 1983;51:452-64.
DOI: https://doi.org/10.1002/1097-0142(19830201)51:3<452::AID-CNCR2820510317>3.0.CO;2-M
Sardaro A, Bardoscia L, Petruzzelli MF, et al. Epithelioid hemangioendothelioma: an overview and update on a rare vascular tumor. Oncol Rev 2014;8:259.
DOI: https://doi.org/10.4081/oncol.2014.259
Weiss SW, Enzinger FM. Epithelioid hemangioendothelioma: a vascular tumor often mistaken for a carcinoma. Cancer 1982;50:970-81.
DOI: https://doi.org/10.1002/1097-0142(19820901)50:5<970::AID-CNCR2820500527>3.0.CO;2-Z
Lau K, Massad M, Pollak C, et al. Clinical patterns and outcome in epithelioid hemangioendothelioma with or without pulmonary involvement: insights from an internet registry in the study of a rare cancer. Chest 2011;140:1312-8.
DOI: https://doi.org/10.1378/chest.11-0039
Kitaichi M, Nagai S, Nishimura K, et al. Pulmonary epithelioid haemangioendothelioma in 21 patients, including three with partial spontaneous regression. Eur Respir J 1998;12:89-96.
DOI: https://doi.org/10.1183/09031936.98.12010089
Anderson T, Zhang L, Hameed M, et al. Thoracic epithelioid malignant vascular tumors: a clinicopathologic study of 52 cases with emphasis on pathologic grading and molecular studies of WWTR1-CAMTA1 fusions. Am J Surg Pathol 2015;39:132-9.
DOI: https://doi.org/10.1097/PAS.0000000000000346
Lin BT, Colby T, Gown AM, et al. Malignant vascular tumors of the serous membranes mimicking mesothelioma. A report of 14 cases. Am J Surg Pathol 1996;20:1431-9.
DOI: https://doi.org/10.1097/00000478-199612000-00001
Stacchiotti S, Provenzano S, Dagrada G, et al. Sirolimus in advanced epithelioid hemangioendothelioma: A retrospective case-series analysis from the Italian Rare Cancer Network Database. Ann Surg Oncol 2016;23:2735-44.
DOI: https://doi.org/10.1245/s10434-016-5331-z
Koch M, Nielsen GP, Yoon SS. Malignant tumors of blood vessels: angiosarcomas, hemangioendotheliomas, and hemangioperictyomas. J Surg Oncol 2008;97:321-9.
DOI: https://doi.org/10.1002/jso.20973
Gaur S, Torabi A, O'Neill TJ. Activity of angiogenesis inhibitors in metastatic epithelioid hemangioendothelioma: a case report. Cancer Biol Med 2012;9:133-6.
van der Graaf WT, Blay JY, Chawla SP, et al. Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet 2012;379:1879-86.
DOI: https://doi.org/10.1016/S0140-6736(12)60651-5
Lee YJ, Chung MJ, Jeong KC, et al. Pleural epithelioid hemangioendothelioma. Yonsei Med J 2008;49:1036-40.
DOI: https://doi.org/10.3349/ymj.2008.49.6.1036
Hatzimichael E, Briasoulis E. Metronomic chemotherapy beyond misconceptions. Haematologica 2013;98:e145.
DOI: https://doi.org/10.3324/haematol.2013.096917
Mavroeidis L, Sheldon H, Briasoulis E, et al. Metronomic vinorelbine: Anti-angiogenic activity in vitro in normoxic and severe hypoxic conditions, and severe hypoxia-induced resistance to its anti-proliferative effect with reversal by Akt inhibition. Int J Oncol 2015;47:455-64.
DOI: https://doi.org/10.3892/ijo.2015.3059
Froudarakis ME, Briasoulis E. Advanced non-small cell lung cancer: on relapse rechallenge the tumor, not the patient. BMC Res Notes 2010;3:195.
DOI: https://doi.org/10.1186/1756-0500-3-195
Briasoulis E, Aravantinos G, Kouvatseas G, et al. Dose selection trial of metronomic oral vinorelbine monotherapy in patients with metastatic cancer: a hellenic cooperative oncology group clinical translational study. BMC Cancer 2013;13:263.
DOI: https://doi.org/10.1186/1471-2407-13-263
Pujol JL, Coffy A, Camerini A, et al. An individual patient-data meta-analysis of metronomic oral vinorelbine in metastatic non-small cell lung cancer. PLoS One 2019;14:e0220988.
DOI: https://doi.org/10.1371/journal.pone.0220988
How to Cite
Anevlavis, Stavros, Georgia Karpathiou, Paschalis Ntolios, and Marios E. Froudarakis. 2022. “Two Years Progression-Free Survival under Vinorelbine Metronomic Therapy of a Patient With Metastatic Epithelioid Hemangioendothelioma”. Monaldi Archives for Chest Disease 92 (4). https://doi.org/10.4081/monaldi.2022.1798.
Copyright (c) 2022 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Similar Articles
- Rafael Martínez-Girón, Liron Pantanowitz, Pulmonary actinomycosis: cytomorphological features , Monaldi Archives for Chest Disease: Vol. 92 No. 2 (2022)
- Rosangela Cocchia, Gianluca Guggino, Luigia Romano, Roberto Annunziata, Antonio Raucci, Mario Sorice, Brigida Ranieri, Giuseppe Russo, Ciro Mauro, Eduardo Bossone, A giant mediastinal teratoma: From diagnosis to complete resection and restitutio ad integrum , Monaldi Archives for Chest Disease: Vol. 92 No. 1 (2022)
- Debapriya Maji, Upasna Agarwal, Lokender Kumar, Vinay V, Amit Sharma, Clinicodemographic profile and outcome of tuberculosis treatment in TB-HIV co-infected patients receiving daily ATT under a single window TB-HIV services delivery initiative , Monaldi Archives for Chest Disease: Vol. 93 No. 3 (2023)
- Marco Umberto Scaramozzino, Guido Levi, Ubaldo Romeo Plastina, Giovanni Sapone, A rare case of asthmatic patient with left Chilaiditi’s syndrome , Monaldi Archives for Chest Disease: Early Access
- Faisal Alamri, Abdalla Eltayeb, Alaa Hamad, Soaad Alamri, Sultan Alamri, Wassima Kaidali, Loay Tashkandi, Lana Arbili, Valeria Pergola, Hani Al Sergani, A native mitral valve mass beyond imagination , Monaldi Archives for Chest Disease: Vol. 94 No. 2 (2024)
- Gian Francesco Mureddu, Cesare Greco, Stefano Rosato, Paola D'Errigo, Leonardo De Luca, Gabriella Badoni, Pompilio Faggiano, Fulvia Seccareccia, High thrombotic risk increases adverse clinical events up to 5 years after acute myocardial infarction. A nationwide retrospective cohort study , Monaldi Archives for Chest Disease: Vol. 89 No. 3 (2019)
- Renato De Vecchis, Andrea Paccone, Marco Di Maio, Atrial mechanical hypofunction after electrical cardioversion of persistent or long-lasting persistent atrial fibrillation: a retrospective cohort study , Monaldi Archives for Chest Disease: Vol. 89 No. 3 (2019)
- Konstantinos Kapriniotis, Angelina Bania, Savvas Lampridis, Georgios Geropoulos, Sofoklis Mitsos, Fleur Monk, David A. Moore, Nikolaos Panagiotopoulos, Metastatic mandibular ameloblastoma of the lung ten years after primary resection: A rare case report , Monaldi Archives for Chest Disease: Vol. 91 No. 2 (2021)
- Fulvio Cacciapuoti, Antonio D’Onofrio, Luca Gaetano Tarquinio, Valentina Capone, Ciro Mauro, Raffaele Marfella, Federico Cacciapuoti, Sleep-disordered breathing and heart failure: a vicious cycle of cardiovascular risk , Monaldi Archives for Chest Disease: Vol. 94 No. 2 (2024)
- Ana Isabel Pinho, Cátia Oliveira, Luís Daniel Santos, Catarina Marques, André Cabrita, Paula Dias, Gonçalo Pestana, Carla Sousa, Rui André Rodrigues, QT interval prolongation in Takotsubo syndrome: a frightening feature with no major prognostic impact , Monaldi Archives for Chest Disease: Early Access
<< < 85 86 87 88 89 90 91 92 93 94 > >>
You may also start an advanced similarity search for this article.
